| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90B | 36.79B | 31.12B | 25.95B | 25.52B | 23.78B |
| Gross Profit | 7.74B | 9.09B | 6.77B | 5.28B | 4.61B | 5.37B |
| EBITDA | 10.06B | 5.67B | 9.21B | 8.00B | 7.22B | 6.14B |
| Net Income | 3.29B | 3.48B | 2.58B | 2.02B | 1.56B | 821.41M |
Balance Sheet | ||||||
| Total Assets | 109.93B | 112.05B | 108.58B | 110.46B | 100.40B | 102.47B |
| Cash, Cash Equivalents and Short-Term Investments | 6.30B | 13.23B | 7.16B | 10.85B | 8.60B | 9.61B |
| Total Debt | 24.96B | 27.60B | 27.05B | 32.14B | 27.30B | 30.76B |
| Total Liabilities | 46.40B | 47.66B | 45.99B | 49.70B | 43.03B | 47.16B |
| Stockholders Equity | 60.81B | 61.60B | 59.91B | 58.13B | 54.85B | 52.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.19B | 1.64B | -1.24B | -163.71M | 7.51B |
| Operating Cash Flow | 0.00 | 10.17B | 5.24B | 784.58M | 2.02B | 8.47B |
| Investing Cash Flow | 0.00 | -2.11B | -3.42B | -3.83B | 1.20B | -449.19M |
| Financing Cash Flow | 0.00 | -2.02B | -5.66B | 5.10B | -4.46B | -5.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥96.30B | 39.51 | 1.46% | 1.18% | 15.23% | 37.37% | |
71 Outperform | ¥42.94B | 12.75 | ― | 2.93% | 18.22% | 35.76% | |
66 Neutral | ¥101.27B | 21.37 | ― | 2.19% | 3.42% | 7.82% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥108.56B | 6.95 | ― | 2.93% | 14.99% | 73.33% | |
58 Neutral | ¥68.39B | 5.01 | ― | ― | 93.14% | 254.99% | |
57 Neutral | ¥61.84B | 9.29 | ― | 2.89% | 4.32% | 11.25% |